Cancer incidence is on the rise, particularly among younger adults, but most new drug compounds fail to progress through clinical trials. According to French entrepreneur Fanny Jaulin (on the right in the picture above), the problem lies with clinical trial design. “Just because a drug isn’t successful in clinical trials doesn’t mean it’s not a […]
© 2024 TechCrunch. All rights reserved. For personal use only.
Related Posts
As SNAP Delays Continue, 10 Ways to Face Food Prices – Civil Eats
Catholic conference on mental health: Dignity is antedote to isolation – Vatican News
‘Let’s tackle that classic Donald Duck butt’: Fitness creator breaks down the 3 most common posture mistakes; expert-backed fixes that work – The Indian Express
D1 Training, Premier Athletic Fitness Brand Expands to Toledo – citybiz
6 Reasons To Move to Irvine, CA, and Why You’ll Love Living Here
190 ChatGPT Prompts Marketers Should Use
Manychat Review: The Automation Chatbot You Need
12 Tips on How to Become an Influencer [+Data]
Leave a Reply